These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 215043)

  • 41. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. VIII. Different catalytic activities of rabbit and rat cytochromes P-448.
    Kawalek JC; Lu AY
    Mol Pharmacol; 1975 Mar; 11(2):201-10. PubMed ID: 235734
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of pretreatment of rabbits with phenobarbital or 3-methylcholanthrene on the distribution of drug-metabolizing enzyme activity in subfractions of hepatic microsomes.
    Gram TE; Rogers LA; Fouts JR
    J Pharmacol Exp Ther; 1967 Aug; 157(2):435-45. PubMed ID: 6039834
    [No Abstract]   [Full Text] [Related]  

  • 43. Intensity of Schistosoma mansoni infection determines alterations in hepatic drug metabolism.
    Naik YS; Hasler JA
    J Egypt Soc Parasitol; 1995 Apr; 25(1):157-63. PubMed ID: 7602158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alterations of hepatic microsomal enzymes in the early phase of murine schistosomiasis.
    Manhães-Rocha DA; Conte FP; Fidalgo-Neto AA; De-Oliveira AC; Ribeiro-Pinto LF; Paumgartten FJ
    Acta Trop; 2005 Jul; 95(1):58-66. PubMed ID: 15862583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification and partial characterization of hepatic microsomal cytochrome P-450s from phenobarbital- and 3-methylcholanthrene-treated rats.
    Masuda-Mikawa R; Fujii-Kuriyama Y; Negishi M; Tashiro Y
    J Biochem; 1979 Nov; 86(5):1383-94. PubMed ID: 118169
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
    Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
    Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration in enzyme activities of de novo phosphatidylcholine biosynthesis in rat liver by treatment with typical inducers of microsomal drug-metabolizing system.
    Ishidate K; Tsuruoka M; Nakazawa Y
    Biochim Biophys Acta; 1980 Oct; 620(1):49-58. PubMed ID: 6251896
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenobarbital- and 3-methylcholanthrene-induced synthesis of two different molecular species of microsomal cytochrome P-450 in rat liver.
    Harada N; Omura T
    J Biochem; 1983 May; 93(5):1361-73. PubMed ID: 6885729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No evidence for an interaction of the bacterial immunomodulator trehalose dimycolate (TDM) with liver drug-metabolizing system in mice.
    Zidek Z; Yanev S
    Immunopharmacol Immunotoxicol; 1987; 9(4):421-8. PubMed ID: 3437104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic microsomes and drug oxidation.
    Estabrook RW
    Science; 1968 Jun; 160(3834):1368-77. PubMed ID: 4385091
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of drug metabolism. VII. Differences in P-420 hemoproteins from untreated and 3-methylcholanthrene-treated rats.
    Shoeman DW; Vane FM; Mannering GJ
    Mol Pharmacol; 1973 May; 9(3):373-82. PubMed ID: 4710137
    [No Abstract]   [Full Text] [Related]  

  • 52. The effects of some stimulators (inducers) of hepatic microsomal drug-metabolizing enzyme activity on substrate-induced difference spectra in rat liver microsomes.
    Kutt H; Waters L; Fouts JR
    J Pharmacol Exp Ther; 1971 Oct; 179(1):101-13. PubMed ID: 5096561
    [No Abstract]   [Full Text] [Related]  

  • 53. Alterations in the carcinogen metabolizing capacities of mouse-liver during schistosoma-mansoni infection.
    Mostafa M; Sheweita S; Elkoweidy A; Badawi A
    Int J Oncol; 1993 Apr; 2(4):695-9. PubMed ID: 21573613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SCHISTOSOME OVA: RAPID SEPARATION FROM MOUSE TISSUE BY DIGESTION WITH PINGUINAIN.
    TORO-GOYCO E; RIVERA-COLLAZO E; RODRIGUEZ-MOLINA R
    Science; 1963 Oct; 142(3590):407-8. PubMed ID: 14056713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of xenobiotic-metabolizing enzymes by trans-stilbene oxide and 2-acetylaminofluorene: observations on enzyme induction by drugs.
    DePierre JW; Seidegård J; Morgenstern R; Balk L; Meijer J; Aström A
    Biochem Soc Trans; 1984 Feb; 12(1):58-60. PubMed ID: 6705989
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of ehxachlorophene on hepatic drug-metabolizing enzymes in the rat.
    Gandolfi AJ; Nakue HS; Buhler DR
    Biochem Pharmacol; 1974 Jul; 23(14):1997-2003. PubMed ID: 4213721
    [No Abstract]   [Full Text] [Related]  

  • 57. Bile composition in bilharzial hepatic fibrosis.
    el Masri SH; Lewin MR; Gumaa K
    Br J Surg; 1977 Jul; 64(7):487-9. PubMed ID: 922308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular mechanisms for changes in hepatic protein synthesis induced by schistosomiasis infection in mice.
    Zern MA; Saber MA; Shafritz DA
    Biochemistry; 1983 Dec; 22(26):6072-7. PubMed ID: 6661426
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of inducers and inhibitors on drug-metabolizing enzymes and on drug toxicity in extrahepatic tissues.
    Boyd MR
    Ciba Found Symp; 1980; 76():43-66. PubMed ID: 6780280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modification of hepatic drug metabolizing enzyme activities and their induction by dietary protein.
    Hietanen E
    Gen Pharmacol; 1980; 11(5):443-50. PubMed ID: 7419037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.